Sol-Gel Technologies (SLGL) Interest Expenses (2016 - 2025)

Sol-Gel Technologies' (SLGL) quarterly Interest Expenses came in at $58.5 million in Q4 2025, up 17.5% year-on-year from $49.8 million in Q4 2024, and up 17.5% on a QoQ basis from $49.8 million in Q4 2024.

Sol-Gel Technologies (SLGL) Interest Expenses (2016 - 2025) Analysis & Trends

Sol-Gel Technologies (SLGL) has 10 years of Interest Expenses data on file, last reported at $58.5 million in Q4 2025.

  • On a quarterly basis, Interest Expenses rose 17.5% year-over-year to $58.5 million in Q4 2025; TTM through Dec 2025 was $58.5 million, a 17.5% increase from a year earlier, with the FY2025 full-year figure at $58.5 million, up 17.5% from the prior year.
  • Interest Expenses for Q4 2025 stood at $58.5 million, up from $49.8 million in the prior quarter.
  • Over the last five years, Interest Expenses for SLGL reached as high as $58.5 million in Q4 2025 and fell as low as $408000.0 in Q4 2021.
  • Historically, Interest Expenses has averaged $40.3 million across 5 years, with a median of $47.9 million in 2023.
  • Across the five-year window, Interest Expenses jumped 10854.41% in 2022 and increased 3.92% in 2024, its largest moves.
  • Year by year, Interest Expenses stood at $408000.0 in 2021, then soared by 10854.41% to $44.7 million in 2022, then increased by 7.2% to $47.9 million in 2023, then grew by 3.92% to $49.8 million in 2024, then climbed by 17.5% to $58.5 million in 2025.
  • Per Business Quant data, the three most recent Interest Expenses figures were $58.5 million in Q4 2025, $49.8 million in Q4 2024, and $47.9 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -42,141.15
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 100,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 32.89 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 1.17 Bn
10 Sol-Gel Technologies 234.04 Mn 223.91 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 58.50 Mn
Dec 31, 2025 58.50 Mn
Dec 31, 2024 49.79 Mn
Dec 31, 2024 49.79 Mn
Dec 31, 2023 47.91 Mn
Dec 31, 2023 47.91 Mn
Dec 31, 2022 44.69 Mn
Dec 31, 2022 44.69 Mn
Dec 31, 2021 408,000.00
Dec 31, 2021 408,000.00
Dec 31, 2020 374,000.00
Dec 31, 2020 374,000.00
Dec 31, 2019 308,000.00
Dec 31, 2019 308,000.00
Dec 31, 2018 262,000.00
Dec 31, 2018 262,000.00
Dec 31, 2017 21.98 Mn
Dec 31, 2017 21.98 Mn
Dec 31, 2016 14.00 Mn
Dec 31, 2016 14.00 Mn